Schmacke, Niklas A., O'Duill, Fionan, Gaidt, Moritz M., Szymanska, Inga, Kamper, Julia M., Schmid-Burgk, Jonathan L., Mädler, Sophia C., Mackens-Kiani, Timur, Kozaki, Tatsuya, Chauhan, Dhruv, Nagl, Dennis, Stafford, Che A., Harz, Hartmann, Fröhlich, Adrian L., Pinci, Francesca, Ginhoux, Florent, Beckmann, Roland, Mann, Matthias, Leonhardt, Heinrich, and Hornung, Veit
The NLRP3 inflammasome plays a central role in antimicrobial defense as well as in the context of sterile inflammatory conditions. NLRP3 activity is governed by two independent signals: the first signal primes NLRP3, rendering it responsive to the second signal, which then triggers inflammasome formation. Our understanding of how NLRP3 priming contributes to inflammasome activation remains limited. Here, we show that IKKβ, a kinase activated during priming, induces recruitment of NLRP3 to phosphatidylinositol-4-phosphate (PI4P), a phospholipid enriched on the trans -Golgi network. NEK7, a mitotic spindle kinase that had previously been thought to be indispensable for NLRP3 activation, was redundant for inflammasome formation when IKKβ recruited NLRP3 to PI4P. Studying iPSC-derived human macrophages revealed that the IKKβ-mediated NEK7-independent pathway constitutes the predominant NLRP3 priming mechanism in human myeloid cells. Our results suggest that PI4P binding represents a primed state into which NLRP3 is brought by IKKβ activity. [Display omitted] • iPSC-derived human macrophages form an NLRP3 inflammasome independently of NEK7 • NLRP3 priming by IKKβ proceeds independently of transcription and substitutes NEK7 • IKKβ activity constitutes the predominant NLRP3 priming mechanism in human cells • IKKβ drives NEK7-independent priming by recruiting NLRP3 to the phospholipid PI4P The NLRP3 inflammasome causes lytic cell death and inflammation, but its activation mechanism remains enigmatic. Schmacke et al. now show that the kinase IKKβ provides an essential priming signal for inflammasome formation by recruiting NLRP3 to the trans -Golgi network. Human cells predominantly use IKKβ instead of the priming factor NEK7. [ABSTRACT FROM AUTHOR]